Platelet-Derived Growth Factor-D And Rho Gtpases Regulate Recruitment of Cancer-Associated Fibroblasts in Cholangiocarcinoma
Massimiliano Cadamuro(University of Padua), Mario Strazzabosco(Smilow Cancer Hospital), Carlo Spirlı̀(Cancer Research Center), Luigi Dall’Olmo, Stefano Indraccolo(University of Padua), Lidia Moserle(Institut d'Investigació Biomédica de Bellvitge), Marco Massani(Ca' Foncello Hospital), Giorgia Nardo(Johannes Gutenberg University Mainz), Tommaso Stecca(Ca' Foncello Hospital), Stuart Morton(University of Padua), Romina Fiorotto(Yale University), M. Colledan(University Hospital Frankfurt), I. Franceschet(University of Padua), Luisa Sambado(University of Padua), Nicolò Bassi(University of Padua), Luca Fabris(University of Padua)
Cited by 167
Related Papers
Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma
|Transplantation|2015|417
Intrahepatic Cholangiocarcinoma: Continuing Challenges and Translational Advances
|Hepatology|2018|340
Abnormal Liver Function Tests in Patients With COVID‐19: Relevance and Potential Pathogenesis
|Hepatology|2020|302
Platelet-derived growth factor-D enables liver myofibroblasts to promote tumor lymphangiogenesis in cholangiocarcinoma
|Journal of Hepatology|2018|187